Disc Medicine (IRON) Liabilities and Shareholders Equity (2020 - 2026)

Disc Medicine (IRON) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $750.2 million in Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $750.2 million, up 5.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.9 billion (up 29.0% YoY), and the FY2025 annual result was $806.9 million, up 62.42% from the prior year.
• Liabilities and Shareholders Equity eased to $750.2 million in Q1 2026 per IRON's latest filing, from $806.9 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $806.9 million in Q4 2025 and troughed at $106.0 million in Q3 2022.
• A 5-year average of $431.4 million and a median of $384.2 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity tumbled 34.37% in 2022, then soared 255.08% in 2023.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $200.2 million in 2022, then soared by 83.81% to $368.0 million in 2023, then surged by 34.99% to $496.8 million in 2024, then soared by 62.42% to $806.9 million in 2025, then dropped by 7.02% to $750.2 million in 2026.
• Business Quant data shows IRON's Liabilities and Shareholders Equity at $750.2 million in Q1 2026, $806.9 million in Q4 2025, and $630.5 million in Q3 2025.